Several studies have reported that biomarkers of inflammation (such as leukocyte count and its subtypes, NLR, C-reactive protein, procalcitonin, and interleukin-6) predicted SAP events in IS patients, and there was a strong association between NLR and pneumonia severity [1, 10–12]. This evidence concerns the gene IL6 and susceptibility to pneumonia measurement.